Adoption of tobacco treatment interventions by substance-abuse-treatment clinicians

被引:15
作者
Friend, KB
Levy, DT
机构
[1] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA
[2] Pacific Inst Res & Evaluat, Calverton, MD USA
关键词
D O I
10.1080/0968763031000105038
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Patients in treatment for substance-use disorders tend to smoke at higher rates than the general population. However, despite the fact such patients may be interested in smoking cessation and have been shown to be able to quit successfully without jeopardizing their sobriety, clinicians are often reluctant to advise their patients to stop smoking. The purpose of this paper is to review factors associated with the adoption of tobacco treatment interventions (TTIs) in the general population and among patients in recovery. We attempt to identify barriers to TTI use and determine where interventions should be directed. Studies were collected using various computerized databases and in consultation experts on tobacco control. We conclude that obstacles to TTI adoption involve the interaction of individual clinician, organizational, and environmental factors, and that changes in all three are needed to increase TTI adoption among substance abuse treatment clinicians. Finally, we offer suggestions regarding where future research is warranted.
引用
收藏
页码:1 / 20
页数:20
相关论文
共 165 条
[1]  
[Anonymous], 1995, Am J Public Health, V85, P183
[2]  
[Anonymous], 2000, Healthy people 2010: understanding and improving health
[3]  
[Anonymous], 2002, Morbidity and Mortality Weekly Report
[4]  
[Anonymous], DHHS PUBL
[5]   A systematic review of the effectiveness of promoting lifestyle change in general practice [J].
Ashenden, R ;
Silagy, C ;
Weller, D .
FAMILY PRACTICE, 1997, 14 (02) :160-175
[6]   Does health habit counseling affect patient satisfaction? [J].
Barzilai, DA ;
Goodwin, MA ;
Zyzanski, SJ ;
Stange, KC .
PREVENTIVE MEDICINE, 2001, 33 (06) :595-599
[7]  
BATEL P, 1995, ADDICTION, V90, P977, DOI 10.1111/j.1360-0443.1995.tb03507.x
[8]   THE CONSEQUENCES OF PRENATAL SUBSTANCE USE FOR THE DEVELOPING FETUS, NEWBORN, AND YOUNG-CHILD [J].
BEHNKE, M ;
EYLER, FD .
INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1993, 28 (13) :1341-1391
[9]  
BENTON A, 2000, MARIANI F P, V9, P1
[10]  
BLOT WJ, 1992, CANCER RES, V52, pS2119